生物活性 | |||
---|---|---|---|
描述 | AP-III-a4 is a novel nonsubstrate analogue inhibitor of enolase, exhibiting an IC50 of 0.576 μM, making it relevant for cancer and diabetes research[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.68mL 0.34mL 0.17mL |
8.41mL 1.68mL 0.84mL |
16.81mL 3.36mL 1.68mL |
参考文献 |
---|